Literature DB >> 23499319

Ketogenic diets and thermal pain: dissociation of hypoalgesia, elevated ketones, and lowered glucose in rats.

David N Ruskin1, Tracey A C S Suter, Jessica L Ross, Susan A Masino.   

Abstract

UNLABELLED: Ketogenic diets (KDs) are high-fat, low-carbohydrate formulations effective in treating medically refractory epilepsy, and recently we demonstrated lowered sensitivity to thermal pain in rats fed a KD for 3 to 4 weeks. Regarding anticonvulsant and hypoalgesic mechanisms, theories are divided as to direct effects of increased ketones and/or decreased glucose, metabolic hallmarks of these diets. To address this point, we characterized the time course of KD-induced thermal hypoalgesia, ketosis, and lowered glucose in young male rats fed ad libitum on normal chow or KDs. A strict 6.6:1 (fat:[carbohydrates + protein], by weight) KD increased blood ketones and reduced blood glucose by 2 days of feeding, but thermal hypoalgesia did not appear until 10 days. Thus, ketosis and decreased glucose are not sufficient for hypoalgesia. After feeding a 6.6:1 KD for 19 days, decreased thermal pain sensitivity and changes in blood chemistry reversed 1 day after return to normal chow. Effects were consistent between 2 different diet formulations: a more moderate and clinically relevant KD formula (3.0:1) produced hypoalgesia and similar changes in blood chemistry as the 6.6:1 diet, thus increasing translational potential. Furthermore, feeding the 3.0:1 diet throughout an extended protocol (10-11 weeks) revealed that significant hypoalgesia and increased ketones persisted whereas low glucose did not, demonstrating that KD-induced hypoalgesia does not depend on reduced glucose. In separate experiments we determined that effects on thermal pain responses were not secondary to motor or cognitive changes. Together, these findings dissociate diet-related changes in nociception from direct actions of elevated ketones or decreased glucose, and suggest mechanisms with a slower onset in this paradigm. Overall, our data indicate that metabolic approaches can relieve pain. PERSPECTIVE: Chronic pain is a common and debilitating condition. We show that a KD, a high-fat, very low carbohydrate diet well known for treating epilepsy, lowers sensitivity to thermal pain in rats. This reduced pain is not temporally correlated with hallmark diet-induced changes in blood glucose and ketones.
Copyright © 2013 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23499319      PMCID: PMC3644372          DOI: 10.1016/j.jpain.2012.12.015

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  59 in total

1.  The analgesic action of baclofen [beta-(4-chlorophenyl)-gamma-aminobutyric acid].

Authors:  R A Levy; H K Proudfit
Journal:  J Pharmacol Exp Ther       Date:  1977-08       Impact factor: 4.030

2.  New hot plate tests to quantify antinociceptive and narcotic antagonist activities.

Authors:  S I Ankier
Journal:  Eur J Pharmacol       Date:  1974-06       Impact factor: 4.432

Review 3.  Prolonged fasting as a method of mood enhancement in chronic pain syndromes: a review of clinical evidence and mechanisms.

Authors:  Andreas Michalsen
Journal:  Curr Pain Headache Rep       Date:  2010-04

Review 4.  Adenosine for pain control.

Authors:  A Sollevi
Journal:  Acta Anaesthesiol Scand Suppl       Date:  1997

5.  A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1J mouse model of Huntington's disease.

Authors:  David N Ruskin; Jessica L Ross; Masahito Kawamura; Tiffany L Ruiz; Jonathan D Geiger; Susan A Masino
Journal:  Physiol Behav       Date:  2011-04-09

6.  Plasma phospholipid fatty acids are influenced by a ketogenic diet enriched with n-3 fatty acids in children with epilepsy.

Authors:  Maria Dahlin; Lena Hjelte; Susanne Nilsson; Per Amark
Journal:  Epilepsy Res       Date:  2006-12-05       Impact factor: 3.045

7.  Polyunsaturated fatty acids and cerebrospinal fluid from children on the ketogenic diet open a voltage-gated K channel: a putative mechanism of antiseizure action.

Authors:  Xiang-ping Xu; Daniel Erichsen; Sara I Börjesson; Maria Dahlin; Per Amark; Fredrik Elinder
Journal:  Epilepsy Res       Date:  2008-05-02       Impact factor: 3.045

Review 8.  [Drug treatment for neuropathic pain].

Authors:  Nadine Attal
Journal:  Presse Med       Date:  2008-01-04       Impact factor: 1.228

9.  Presynaptic K-channel blockade counteracts the depressant effect of adenosine in olfactory cortex.

Authors:  C N Scholfield; L Steel
Journal:  Neuroscience       Date:  1988-01       Impact factor: 3.590

Review 10.  The neuropharmacology of the ketogenic diet.

Authors:  Adam L Hartman; Maciej Gasior; Eileen P G Vining; Michael A Rogawski
Journal:  Pediatr Neurol       Date:  2007-05       Impact factor: 3.372

View more
  9 in total

1.  Laboratory environmental factors and pain behavior: the relevance of unknown unknowns to reproducibility and translation.

Authors:  Jeffrey S Mogil
Journal:  Lab Anim (NY)       Date:  2017-03-22       Impact factor: 12.625

Review 2.  Ketogenic diets and pain.

Authors:  Susan A Masino; David N Ruskin
Journal:  J Child Neurol       Date:  2013-05-16       Impact factor: 1.987

3.  Effects of a ketogenic diet on hippocampal plasticity in freely moving juvenile rats.

Authors:  J Harry Blaise; David N Ruskin; Jessica L Koranda; Susan A Masino
Journal:  Physiol Rep       Date:  2015-05

4.  Ketogenic diets improve behaviors associated with autism spectrum disorder in a sex-specific manner in the EL mouse.

Authors:  David N Ruskin; Jessica A Fortin; Subrina N Bisnauth; Susan A Masino
Journal:  Physiol Behav       Date:  2016-11-09

5.  Ketogenic diet improves behaviors in a maternal immune activation model of autism spectrum disorder.

Authors:  David N Ruskin; Michelle I Murphy; Sierra L Slade; Susan A Masino
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240

6.  Ketone-Based Metabolic Therapy: Is Increased NAD+ a Primary Mechanism?

Authors:  Marwa Elamin; David N Ruskin; Susan A Masino; Paola Sacchetti
Journal:  Front Mol Neurosci       Date:  2017-11-14       Impact factor: 5.639

7.  Ketogenic diet effects on inflammatory allodynia and ongoing pain in rodents.

Authors:  David N Ruskin; Isabella C Sturdevant; Livia S Wyss; Susan A Masino
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

Review 8.  The Effect of Ketogenic Diet on Inflammatory Arthritis and Cardiovascular Health in Rheumatic Conditions: A Mini Review.

Authors:  Jacopo Ciaffi; Dmitri Mitselman; Luana Mancarella; Veronica Brusi; Lucia Lisi; Piero Ruscitti; Paola Cipriani; Riccardo Meliconi; Roberto Giacomelli; Claudio Borghi; Francesco Ursini
Journal:  Front Med (Lausanne)       Date:  2021-12-14

9.  Ketogenic diet sensitizes glucose control of hippocampal excitability.

Authors:  Masahito Kawamura; David N Ruskin; Jonathan D Geiger; Detlev Boison; Susan A Masino
Journal:  J Lipid Res       Date:  2014-08-28       Impact factor: 5.922

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.